Your browser doesn't support javascript.
loading
Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.
Wang, Feng-Hua; Wang, Yun; Sun, Guo-Ping; Chen, Jian-Hua; Lin, Ying-Cheng; Liu, Wei; Zheng, Rong-Sheng; Chen, Jia; Zhang, He-Long; Lan, Hai-Tao; Qi, Jun; Liu, Yang-Qing; Deng, Yan-Ming; Zhao, Heng; Xiong, Jian-Ping; Xu, Qing; Jiang, Wen-Qi; Li, Yu-Hong.
Afiliação
  • Wang FH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wang Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, People's Republic of China.
  • Sun GP; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chen JH; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, People's Republic of China.
  • Lin YC; Department of Medical Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Liu W; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, People's Republic of China.
  • Zheng RS; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
  • Chen J; Department of Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Zhang HL; Department of Medical Oncology, Anhui Provincial Cancer Hospital, Bengbu, People's Republic of China.
  • Lan HT; Department of Oncology, Jiangsu Cancer Hospital, Nanjing, People's Republic of China.
  • Qi J; Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, People's Republic of China.
  • Liu YQ; Department of Oncology, Sichuan Provincial People's Hospital, Chengdu, People's Republic of China.
  • Deng YM; Department of Thoracic Surgery, Chongqing Cancer Hospital, Chongqing, People's Republic of China.
  • Zhao H; Department of Medical Oncology, Huai'an First People's Hospital, Huai'an, People's Republic of China.
  • Xiong JP; Department of Medical Oncology, First People's Hospital of Foshan, Foshan, People's Republic of China.
  • Xu Q; Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Jiang WQ; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
  • Li YH; Department of Oncology, Shanghai 10th People's Hospital, Shanghai, People's Republic of China.
Cancer ; 123(20): 3986-3994, 2017 Oct 15.
Article em En | MEDLINE | ID: mdl-28640389
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfotoxina-alfa Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfotoxina-alfa Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2017 Tipo de documento: Article